Filing Details

Accession Number:
0000711377-16-000067
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-18 13:16:54
Reporting Period:
2016-02-16
Filing Date:
2016-02-18
Accepted Time:
2016-02-18 13:16:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-02-16 42,000 $28.67 924,564 No 4 M Direct
Common Stock Disposition 2016-02-16 31,500 $48.02 893,064 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2016-02-16 42,000 $0.00 42,000 $28.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
249,502 2017-10-04 No 4 M Direct
Footnotes
  1. Options were granted on 10/4/2012, have five year lives, and vest in equal annual installments on each anniversary date of the grant
  2. Shares were sold to cover the cost of the option exercise